Oxford Nanopore has continued its funding streak with another $108m, bringing this year's haul to more than $208m and its overall total to around $800m.
Oxford Nanopore, a UK-based genetic sequencing technology spinout of University of Oxford, obtained £84.4m ($108m) in funding today from a consortium including pension fund manager RPMI Railpen.
The deal was backed by a group of new and existing investors including diversified holding group International Holdings Company.
Founded in 2005, Oxford Nanopore produces DNA and RNA sequencing technologies used for medical research and diagnostics in addition to applications in environmental, plant and animal science.
The offering includes a…
